superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2011-12-31
- Valid until
- 2012-12-31
- Published
- 2012-02-21
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 750,269,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals net income: -221,760,000 United States dollar", as of 2011-12-31 (until 2012-12-31). Claim clm_F3AAA9683DBE, https://asof.is/claim/clm_F3AAA9683DBE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm.
APA
AsOf. (2011). Regeneron Pharmaceuticals net income: -221,760,000 United States dollar (as of 2011-12-31 (until 2012-12-31)) [Record clm_F3AAA9683DBE]. Retrieved November 9, 2026, from https://asof.is/claim/clm_F3AAA9683DBE (source: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm)
BibTeX
@misc{asof_clm_F3AAA9683DBE,
author = {AsOf},
title = {Regeneron Pharmaceuticals net income: -221,760,000 United States dollar},
year = {2011},
howpublished = {\url{https://asof.is/claim/clm_F3AAA9683DBE}},
note = {Claim clm\_F3AAA9683DBE, as of 2011-12-31 (until 2012-12-31); source: https://www.sec.gov/Archives/edgar/data/872589/000120677412000709/0001206774-12-000709-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_F3AAA9683DBE.md/v1/claims/clm_F3AAA9683DBEsubmit a correction